152 related articles for article (PubMed ID: 16960411)
1. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O
Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411
[TBL] [Abstract][Full Text] [Related]
2. The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure.
Yildirir A; Sade E; Tokgozoglu L; Oto A
Eur J Heart Fail; 2001 Dec; 3(6):717-21. PubMed ID: 11738224
[TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
Oflaz MB; Balli S; Kibar AE; Ece I; Akdeniz C; Tuzcu V
Med Sci Monit; 2013 May; 19():366-72. PubMed ID: 23686300
[TBL] [Abstract][Full Text] [Related]
4. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
[TBL] [Abstract][Full Text] [Related]
5. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
Aygul N; Ozdemir K; Duzenli MA; Aygul MU
Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
[TBL] [Abstract][Full Text] [Related]
6. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
[TBL] [Abstract][Full Text] [Related]
7. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol on heart rate dynamics in patients with congestive heart failure.
Ridha M; Mäkikallio TH; Lopera G; Pastor J; de Marchena E; Chakko S; Huikuri HV; Castellanos A; Myerburg RJ
Ann Noninvasive Electrocardiol; 2002 Apr; 7(2):133-8. PubMed ID: 12049685
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure.
Chiu KM; Chan HL; Chu SH; Lin TY
Auton Neurosci; 2007 Mar; 132(1-2):76-80. PubMed ID: 17157564
[TBL] [Abstract][Full Text] [Related]
10. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
11. Effects of carvedilol on ventricular arrhythmias.
Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.
Pamboukian SV; Aminbakhsh A; Thompson CR; Amin H; Mortimer S; D'yachkova Y; Ignaszweski AP
Clin Transplant; 1999 Oct; 13(5):426-31. PubMed ID: 10515224
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy.
Piccirillo G; Quaglione R; Nocco M; Naso C; Moisè A; Lionetti M; Di Carlo S; Marigliano V
Am J Cardiol; 2002 Nov; 90(10):1113-7. PubMed ID: 12423713
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly?
Rocha RM; Silva GV; Perin EC; Gerk AR; Gouvea EP; Santos VM; Filho FM; de Albuquerque DC
Tex Heart Inst J; 2003; 30(3):176-9. PubMed ID: 12959198
[TBL] [Abstract][Full Text] [Related]
16. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
17. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
18. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
[TBL] [Abstract][Full Text] [Related]
19. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
